Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Si-Ni-Tang for Severe Sepsis
NCT02777606Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Si-Ni-Tang in sepsis (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: 28-day all-cause mortality rate. Started Jun 2016; status: completed.
02
Drugs
Si-Ni-Tang
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT02777606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777606.